Boss also lowered his FY gross margin to 58.8%, representing a 70-basis point decline year-over-year, attributed to headwinds ...

In last year's update, AbbVie raised the combined 2027 net sales guidance for Skyrizi and Rinvoq by $6 billion to $27 billion ...

J.P. Morgan analyst Ranjan Sharma maintained a Buy rating on Grab (GRAB – Research Report) on January 21 and set a price target of $5.60. The ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

Investing.com -- J.P. Morgan analysts have upgraded their rating for Aviva plc (LON: AV) to "overweight" from "neutral," ...

J.P. Morgan analyst Mark Strouse maintained a Hold rating on Bloom Energy (BE – Research Report) yesterday and set a price target of $16.00.

Investing.com -- J.P. Morgan downgraded PVH Corp (NYSE: PVH) to "Neutral" on a slower-than-expected recovery in topline growth amid global macroeconomic challenges and foreign exchange pressures.

Looking forward, we expect oil demand to rebound in the coming weeks, averaging 101.4 million barrels per day'.

The S&P 500 shook off the December doldrums to touch a new intraday high of 6,100.81 on Thursday. It’s also just a hair away ...

"For us, corporate responsibility means using all the firm's resources — ranging from research and policy to community ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...